July 15 Clinical Quick Takes Zejula meets in Phase III for 1L ovarian cancer; plus Capricor Avrobio and NIH
July 15 Clinical Quick Takes: Zejula meets in Phase III for 1L ovarian cancer; plus Capricor, Avrobio and NIH
More From BioPortfolio on "July 15 Clinical Quick Takes: Zejula meets in Phase III for 1L ovarian cancer; plus Capricor, Avrobio and NIH"